In colon cancer and thyroid cancer patients, CTHRC1 expression levels were negatively associated with OS, and univariate COX regression analysis showed that CTHRC1 was an important risk factor correlated with patient OS rates. This evidence concerns the gene CTHRC1 and colonic neoplasm.